Sepsis during short bowel syndrome hospitalizations: Identifying trends, disparities, and clinical outcomes in the United States

Table 4 Racial distribution of Elixhauser co-morbidities for septic short bowel syndrome hospitalizations in the United States from 2005-2014

Elixhauser co-morbidity	Whites	Blacks	Hispanics	Others	P value
Acquired immunodeficiency syndrome	0.0	1.0	0.3	0.0	< 0.0001
Alcohol abuse	1.6	2.4	0.8	1.4	< 0.0001
Deficiency anemias	38.8	49.0	45.4	37.6	< 0.0001
Rheumatic disorders	4.3	4.1	2.9	4.0	0.0040
Chronic blood loss anemia	2.1	2.1	2.3	3.2	0.0200
Congestive heart failure	11.2	10.8	8.6	9.8	< 0.0001
Chronic pulmonary disease	19.7	14.6	10.6	18.4	< 0.0001
Coagulopathy	15.4	16.9	19.1	16.9	< 0.0001
Depression	18.0	10.9	14.2	11.5	< 0.0001
Uncomplicated diabetes	11.4	14.4	17.7	17.0	< 0.0001
Diabetes with chronic complications	2.8	5.8	5.4	5.0	< 0.0001
Drug abuse	4.8	6.6	4.4	5.0	< 0.0001
Hypertension	32.4	42.5	34.5	34.6	< 0.0001
Hypothyroidism	13.5	10.4	8.8	8.6	< 0.0001
Liver disease	5.8	7.0	9.9	6.9	< 0.0001
Lymphoma	1.1	1.1	1.2	0.9	0.7500
Fluid and electrolyte disorders	57.5	62.5	61.2	58.2	< 0.0001
Metastatic cancer	4.5	4.4	5.2	8.6	< 0.0001
Neurological disorders	8.8	8.3	6.7	7.9	0.001
Obesity	5.6	6.3	5.7	6.9	0.0300
Paralysis	2.3	3.3	4.2	4.9	< 0.0001
Peripheral vascular disorders	6.8	7.4	7.0	6.5	0.4300
Psychiatric disorder	6.1	5.5	5.6	4.1	0.0030
Pulmonary circulation disorders	4.0	5.5	2.3	3.4	< 0.0001
Renal failure	21.2	30.7	16.7	18.8	< 0.0001
Solid tumor without metastasis	2.6	2.8	2.9	5.2	< 0.0001
Peptic ulcer disease excluding bleeding	0.1	0.1	0.1	0.0	0.3400
Valvular disease	5.2	4.8	3.8	5.3	0.0050
Weight loss	40.4	40.9	39.3	47.9	< 0.0001